29
Views
7
CrossRef citations to date
0
Altmetric
Original Article

High Levels of Autoantibodies against Drug-metabolizing Enzymes in SLA/LP-positive AIH-1 Sera

, , , , , & show all
Pages 473-480 | Received 10 Mar 2004, Accepted 09 Jul 2004, Published online: 07 Jul 2009

References

  • Dalekos, G.N., Zachou, K., Liaskos, C. and Gatselis, N. (2002) "Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview", Eur J. Intern. Med. 13, 293–303.
  • Costa, M., Rodriguez-Sanchez, J.L., Czaja, A.J. and Gelpi, C. (2000) "Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients with type-1 autoimmune hepatitis", Clin. Exp. Immunol. 121, 364–374.
  • Wies, I., Brunner, S., Henninger, J., Herkel, J., Kanzler, S., Meyer zum Buschenfolde, K.H. and Lohse, A.W. (2000) "Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis", Lancet 355, 1510–1515.
  • Kernebeck, T., Lohse, A.W. and Grotzinger, J. (2001) "A bioinformational approach suggests the function of the autoimmune hepatitis target antigen SLA/LP", Hepatology 34, 230–233.
  • Mizutani, T. and Goto, C. (2000) "Eukaryotic selenocysteine tRNA has the 9/4 secondary structure", FEBS Lett. 466, 359–362.
  • Fagegaltier, D., Hubert, N., Yamada, K., Mizutani, T., Carbon, P. and Krol, A. (2000) "Characterization of mSelB, a novel mammalian elongation factor for selenoprotein translation", EMBO J. 19, 4796–4805.m Ma, Y., Thomas, M.G., Okamoto, M., Bogdanos, D.P., Nagl, S., Kerkar, N., Lopes, A.R., Muratori, L., Lenzi, M., Bianchi, F.B., Mieli-Vergani, G. and Vergani, D. (2002) "Key residues of a major

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.